Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Neil Roy, M.B.,B.S.

Concepts (42)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Neil Roy's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Neil Roy has written about over time.
Amphetamine, 1 publications between 2019 and 2019, average publication date October 2019. Labetalol, 1 publications between 2019 and 2019, average publication date October 2019. Antirheumatic Agents, 1 publications between 2021 and 2021, average publication date January 2021. Glomerulonephritis, 1 publications between 2021 and 2021, average publication date January 2021. Erectile Dysfunction, 1 publications between 2021 and 2021, average publication date March 2021. Prospective Studies, 2 publications between 2021 and 2021, average publication date June 2021. Kidney Transplantation, 1 publications between 2021 and 2021, average publication date June 2021. Multiple Myeloma, 1 publications between 2021 and 2021, average publication date June 2021. C-Reactive Protein, 1 publications between 2021 and 2021, average publication date September 2021. Disease Progression, 1 publications between 2021 and 2021, average publication date September 2021. Interleukin-6, 1 publications between 2021 and 2021, average publication date September 2021. Coronary Artery Disease, 3 publications between 2021 and 2022, average publication date October 2021. Renal Dialysis, 3 publications between 2021 and 2022, average publication date October 2021. Adipokines, 1 publications between 2022 and 2022, average publication date June 2022. Adiponectin, 1 publications between 2022 and 2022, average publication date June 2022. Cardiovascular Diseases, 1 publications between 2022 and 2022, average publication date June 2022. Leptin, 1 publications between 2022 and 2022, average publication date June 2022. Resistin, 1 publications between 2022 and 2022, average publication date June 2022. Diabetes Mellitus, Type 1, 1 publications between 2022 and 2022, average publication date October 2022.

To see the data from this visualization as text, click here.
Roy's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (42)
Explore
_
Co-Authors (6)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.